Literature DB >> 23096706

MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.

Neehar Bhatia1, Tony Z Xiao2, Kimberly A Rosenthal2, Imtiaz A Siddiqui2, Saravanan Thiyagarajan3, Brendan Smart2, Qiao Meng4, Cindy L Zuleger5, Hasan Mukhtar2, Shannon C Kenney4, Mark R Albertini6, B Jack Longley7.   

Abstract

Melanoma-associated antigen-encoding (MAGE) genes are expressed in melanoma and other cancers but not in normal somatic cells. MAGE expression is associated with aggressive tumor growth, poor clinical outcome, and resistance to chemotherapy, but the mechanisms have not been completely elucidated. In this study, we show that downregulation of MAGE-C2 in A375 melanoma cells and low-passage cultures from human metastatic melanomas (MRA cells) results in increased apoptosis and decreased growth of tumor xenografts in athymic nude mice. Previously, we showed that MAGE-C2 binds KAP1, a scaffolding protein that regulates DNA repair. Phosphorylation of KAP1-Serine 824 (Ser824) by ataxia-telangiectasia-mutated (ATM) kinase is necessary for repair of DNA double-strand breaks (DSBs); now we show that MAGE-C2 knockdown reduces, whereas MAGE-C2 overexpression increases, ATM kinase-dependent phosphorylation of KAP1-Ser824. We demonstrate that MAGE-C2 increases co-precipitation of KAP1 with ATM and that binding of MAGE-C2 to KAP1 is necessary for increased KAP1-Ser824 phosphorylation. Furthermore, ectopic expression of MAGE-C2 enhances repair of I-SceI endonuclease-induced DSBs in U-2OS cells. As phosphorylation of KAP1-Ser824 facilitates relaxation of heterochromatin, which is necessary for DNA repair and cellular proliferation, our results suggest that MAGE-C2 can promote tumor growth by phosphorylation of KAP1-Ser824 and by enhancement of DNA damage repair.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096706      PMCID: PMC3570725          DOI: 10.1038/jid.2012.355

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  39 in total

Review 1.  Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review).

Authors:  Leonie Smeenk; Marion Lohrum
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

2.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

3.  Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.

Authors:  Bing Yang; Sean O'Herrin; Jianqiang Wu; Shannon Reagan-Shaw; Yongsheng Ma; Minakshi Nihal; B Jack Longley
Journal:  J Invest Dermatol       Date:  2006-09-07       Impact factor: 8.551

4.  Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.

Authors:  Suzanne Svobodová; Judy Browning; Duncan MacGregor; Gabriele Pollara; Richard A Scolyer; Rajmohan Murali; John F Thompson; Siddhartha Deb; Arun Azad; Ian D Davis; Jonathan S Cebon
Journal:  Eur J Cancer       Date:  2010-11-04       Impact factor: 9.162

5.  MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.

Authors:  G F Hofbauer; C Schaefer; C Noppen; R Böni; J Kamarashev; F O Nestle; G C Spagnoli; R Dummer
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

6.  Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.

Authors:  Ran Zhuang; Yong Zhu; Liang Fang; Xue-Song Liu; Ying Tian; Li-Hua Chen; Wei-Ming Ouyang; Xiao-Guang Xu; Jin-Long Jian; Ali O Güre; Sheila Fortunato; Gerd Ritter; Lloyd J Old; Andrew J G Simpson; Yao T Chen; Boquan Jin; Achim A Jungbluth
Journal:  Cancer Immun       Date:  2006-04-05

7.  Morphometrical quantification of spermatogonial germ cells with the 57B anti-MAGE-A4 antibody in the evaluation of testicular biopsies for azoospermia.

Authors:  Evgeny Yakirevich; Edmond Sabo; Martha Dirnfeld; Yanina Sova; Giulio C Spagnoli; Murray B Resnick
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-03

8.  MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.

Authors:  Martin Monte; Marta Simonatto; Leticia Y Peche; Debora R Bublik; Stefania Gobessi; Marco A Pierotti; Monica Rodolfo; Claudio Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

9.  The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma.

Authors:  E Rajpert-De Meyts; G K Jacobsen; J Bartkova; F Aubry; M Samson; J Bartek; N E Skakkebaek
Journal:  Histopathology       Date:  2003-03       Impact factor: 5.087

10.  Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors.

Authors:  Filippo Bellati; Chiara Napoletano; Elisabetta Tarquini; Innocenza Palaia; Rachele Landi; Natalina Manci; Giulio Spagnoli; Aurelia Rughetti; Pierluigi Benedetti Panici; Marianna Nuti
Journal:  Eur J Cancer       Date:  2007-10-22       Impact factor: 9.162

View more
  27 in total

1.  Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.

Authors:  Johannes A Veit; Daniela Heine; Julia Thierauf; Jochen Lennerz; Subasch Shetty; Patrick J Schuler; Theresa Whiteside; Dirk Beutner; Moritz Meyer; Inga Grünewald; Gerd Ritter; Sacha Gnjatic; Andrew G Sikora; Thomas K Hoffmann; Simon Laban
Journal:  Head Neck       Date:  2016-02-13       Impact factor: 3.147

2.  The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.

Authors:  X Song; J Hao; J Wang; C Guo; Y Wang; Q He; H Tang; X Qin; Y Li; Y Zhang; Y Yin
Journal:  Oncogene       Date:  2016-10-24       Impact factor: 9.867

3.  High expression of MAGE-C1 gene in colorectal cancer is associated with its poor prognosis.

Authors:  Yu Tian; Ping Liang; Lihua Zhang; Xiufen Zhang; Xiaoli Wang; Yufen Jin; Xiaowei Qi; Yankui Liu
Journal:  J Gastrointest Oncol       Date:  2021-12

4.  KAP1 phosphorylation promotes the survival of neural stem cells after ischemia/reperfusion by maintaining the stability of PCNA.

Authors:  Wan Wang; Tianqing Yan; Xinjian Guo; Heng Cai; Chang Liang; Linyan Huang; Yanling Wang; Ping Ma; Suhua Qi
Journal:  Stem Cell Res Ther       Date:  2022-07-07       Impact factor: 8.079

Review 5.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

6.  MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity.

Authors:  Tony Z Xiao; Yewseok Suh; B Jack Longley
Journal:  Arch Biochem Biophys       Date:  2014-08-07       Impact factor: 4.013

Review 7.  The MAGE protein family and cancer.

Authors:  Jenny L Weon; Patrick Ryan Potts
Journal:  Curr Opin Cell Biol       Date:  2015-09-03       Impact factor: 8.382

Review 8.  Oncogenic cancer/testis antigens: prime candidates for immunotherapy.

Authors:  Morten F Gjerstorff; Mads H Andersen; Henrik J Ditzel
Journal:  Oncotarget       Date:  2015-06-30

9.  The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.

Authors:  Lucie Kozakova; Lucie Vondrova; Karel Stejskal; Panagoula Charalabous; Peter Kolesar; Alan R Lehmann; Stjepan Uldrijan; Christopher M Sanderson; Zbynek Zdrahal; Jan J Palecek
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 10.  ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development.

Authors:  Liem Minh Phan; Abdol-Hossein Rezaeian
Journal:  Genes (Basel)       Date:  2021-05-30       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.